![Louise Rodino-Klapac](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Louise Rodino-Klapac
Chief Tech/Sci/R&D Officer at
SAREPTA THERAPEUTICS, INC.
Net worth: 975 059 $ as of 30/05/2026
Profile
Founder of Myonexus Therapeutics, Inc., Louise Rodino-Klapac is on the board of Alliance for Regenerative Medicine and Aavantibio, Inc. and Chief Scientific Officer & Executive VP at Sarepta Therapeutics, Inc., Member of American Academy of Neurology and Member of American Society of Gene & Cell Therapy. She previously occupied the position of Chief Scientific Officer at Myonexus Therapeutics, Inc. and Head-Laboratory for Gene Therapy Research at Nationwide Children's Hospital. She received an undergraduate degree from King's College (Pennsylvania) and a doctorate from The Ohio State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 07/04/2026 | 54,564 ( 0.05% ) | 975 059 $ | 30/05/2026 |
Louise Rodino-Klapac active positions
| Companies | Position | Start |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 13/12/2020 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Director/Board Member | 31/12/2020 |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Corporate Officer/Principal | - |
American Academy of Neurology
 American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Corporate Officer/Principal | - |
Former positions of Louise Rodino-Klapac
| Companies | Position | End |
|---|---|---|
Nationwide Children's Hospital
 Nationwide Children's Hospital Hospital/Nursing ManagementHealth Services Operates children's hospitals | Corporate Officer/Principal | 31/05/2019 |
Myonexus Therapeutics, Inc.
 Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for limb-girdle muscular dystrophies | Founder | 31/03/2019 |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Director/Board Member | - |
Training of Louise Rodino-Klapac
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
43
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
King's College (Pennsylvania)
 King's College (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Commercial Services |
Nationwide Children's Hospital
Nationwide Children's Hospital Hospital/Nursing ManagementHealth Services Operates children's hospitals | Health Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Commercial Services |
Myonexus Therapeutics, Inc.
Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for limb-girdle muscular dystrophies | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
- Stock Market
- Insiders
- Louise Rodino-Klapac
